Non-insulin-dependent type 2 diabetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: Before starting the main intervention, all the selected people enter the Run-in period for two weeks, to collect complete information about the
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: At least 6 months and a maximum of 10 years have passed since the diagnosis of the disease by a doctor. Having diabetes diagnosed based on laboratory findings and the opinion of an endocrinologist. Willingness to cooperate in this study Age above 30 and less than 60 years Body mass index above 30 and below 40 kg/m2 Patients who are not candidates for bariatric surgery
Exclusion criteria
Exclusion criteria: At least 6 months and at most 10 years have passed since the diagnosis of the disease by a doctor. Having diabetes diagnosed based on laboratory findings and the opinion of an endocrinologist. Being willing to cooperate in this study Being willing to cooperate in this study Body mass index above 30 and below 40 kg/m2 Patients who are not candidates for bariatric surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of lipid parameters (T.G, T.C, LDL, HDL). Timepoint: Before the intervention and 12 weeks later. Method of measurement: Pars test kit and spectrophotometry method.;Serum levels of blood sugar profiles (FBS, HbA1C, HOMA-IR, HOMA-B). Timepoint: Before the intervention and 12 weeks later. Method of measurement: Diagnostic kits.;Serum levels of oxidative stress markers (MDA). Timepoint: Before the intervention and 12 weeks later. Method of measurement: Pars test kit and spectrophotometry method.;Serum levels of inflammatory markers (hs-CRP, IL-6, TNF-a). Timepoint: Before the intervention and 12 weeks later. Method of measurement: kit Eliza. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic and diastolic blood pressure. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Sphygmomanometer and calibrated stethoscope.;Sleep quality score. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Sleep quality questionnaire.;Carbohydrate, protein, fat and fiber intake. Timepoint: Before the intervention and 12 weeks later. Method of measurement: 24-hour food recall questionnaire.;New anthropometric indices (Tyg, WT, VAI, WT). Timepoint: Before the intervention and 12 weeks later. Method of measurement: Calculate.;Calculating the risk of chronic diseases using the ASCVD and Framingham criteria. Timepoint: Before the intervention and 12 weeks later. Method of measurement: Calculate. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Imani
Tehran University of Medical Sciences
Outcome results
None listed